SLC6A3 and attention deficit-hyperactivity disorder: Functional imaging studies, such as positron emission tomography, which utilize selective ligands for the dopamine transporter (DAT), documented amplified DAT binding capacity in up to 70% of ADHD patients, designating a greater density of DAT in the ADHD brains than in controls [5,6].